NCT01182935

Brief Summary

Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,509

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 17, 2010

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
Last Updated

July 20, 2011

Status Verified

July 1, 2011

Enrollment Period

5 months

First QC Date

August 11, 2010

Last Update Submit

July 19, 2011

Conditions

Keywords

vitamin Dtriglyceridestype 2 diabetes

Outcome Measures

Primary Outcomes (1)

  • Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT)

    At study enrollment in 2010

Secondary Outcomes (1)

  • The relation between serum 25(OH)D levels and blood glucose levels at OGTT

    At study enrollment in 2010

Study Arms (1)

participants in the 4th Tromsø study

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

participants in the 4 Tromsø study 1994 and with elevated serum triglyceride levels

You may qualify if:

  • participants in the 4 Tromso study 1994 and with elevated serum triglyceride levels

You may not qualify if:

  • type 2 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univesity of Tromsø

Tromsø, Tromsø, 9037, Norway

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

serum

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • rolf jorde, md

    University of Tromso

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 11, 2010

First Posted

August 17, 2010

Study Start

April 1, 2010

Primary Completion

September 1, 2010

Study Completion

November 1, 2010

Last Updated

July 20, 2011

Record last verified: 2011-07

Locations